Irinotecan activates anti-tumor immunity in CT26 subcutaneous tumors
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP466491
下载链接
链接失效反馈官方服务：
资源简介：
Topoisomerase I (Top1) is a classical drug target for anticancer therapy, but its role in immune signaling in cancer cells remain unclear. Here, we aimed to explore the possible role and mechanism of Irinotecan (CPT-11) in anti-tumor immunity. Overall design: CT26 subcutaneous tumors mRNA profiles of Control and CPT-11 tretment mice were generated by deep sequencing, in duplicate.
创建时间：
2025-10-16
